388 related articles for article (PubMed ID: 25780994)
1. Extended pelvic lymph node dissection for clinically localized prostate cancer: a West Australian experience.
Picardo A; Vivian J
ANZ J Surg; 2015 Dec; 85(12):936-40. PubMed ID: 25780994
[TBL] [Abstract][Full Text] [Related]
2. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
3. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
McGinley KF; Sun X; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
Int J Urol; 2016 Mar; 23(3):241-6. PubMed ID: 26667212
[TBL] [Abstract][Full Text] [Related]
4. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
5. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
[TBL] [Abstract][Full Text] [Related]
7. Impact of a single-surgeon learning curve on complications, positioning injuries, and renal function in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection.
Di Pierro GB; Wirth JG; Ferrari M; Danuser H; Mattei A
Urology; 2014 Nov; 84(5):1106-11. PubMed ID: 25443913
[TBL] [Abstract][Full Text] [Related]
8. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
[TBL] [Abstract][Full Text] [Related]
9. Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes.
Sagalovich D; Calaway A; Srivastava A; Sooriakumaran P; Tewari AK
BJU Int; 2013 Jan; 111(1):85-94. PubMed ID: 22823452
[TBL] [Abstract][Full Text] [Related]
10. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
11. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
Preisser F; van den Bergh RCN; Gandaglia G; Ost P; Surcel CI; Sooriakumaran P; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Salomon L; Ploussard G; Tilki D;
J Urol; 2020 Feb; 203(2):338-343. PubMed ID: 31437119
[TBL] [Abstract][Full Text] [Related]
12. Robot-Assisted Extended Pelvic Lymph Nodes Dissection for Prostate Cancer: Personal Surgical Technique and Outcomes.
Porpiglia F; De Luca S; Bertolo R; Passera R; Mele F; Manfredi M; Amparore D; Morra I; Fiori C
Int Braz J Urol; 2015; 41(6):1209-12019. PubMed ID: 26742982
[TBL] [Abstract][Full Text] [Related]
13. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histopathological and molecular analyses.
Bando Y; Hinata N; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
Prostate; 2020 Mar; 80(4):345-351. PubMed ID: 31899555
[TBL] [Abstract][Full Text] [Related]
15. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
[TBL] [Abstract][Full Text] [Related]
16. Extended pelvic lymphadenectomy in patients with clinically localised prostate cancer: A prospective observational study.
Ramos JG; Caicedo JI; Cataño JG; Villarraga LG; Trujillo CG; Robledo D; Plata M
Actas Urol Esp; 2016 Sep; 40(7):446-52. PubMed ID: 26995770
[TBL] [Abstract][Full Text] [Related]
17. Comparing conventional laparoscopic to robotic-assisted extended pelvic lymph node dissection in men with intermediate and high-risk prostate cancer: a matched-pair analysis.
Albisinni S; Aoun F; LE Dinh D; Zanaty M; Hawaux E; Peltier A; VAN Velthoven R
Minerva Urol Nefrol; 2017 Feb; 69(1):101-107. PubMed ID: 28009151
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB
Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.
Harke NN; Godes M; Wagner C; Addali M; Fangmeyer B; Urbanova K; Hadaschik B; Witt JH
World J Urol; 2018 Nov; 36(11):1817-1823. PubMed ID: 29767326
[TBL] [Abstract][Full Text] [Related]
20. Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database.
Wang EH; Yu JB; Gross CP; Smaldone MC; Shah ND; Trinh QD; Nguyen PL; Sun M; Han LC; Kim SP
J Urol; 2015 Mar; 193(3):820-5. PubMed ID: 25242393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
